Roberto Cuca - 14 Nov 2023 Form 4 Insider Report for TELA Bio, Inc. (TELA)

Role: COO and CFO
Signature: /s/ Megan Smeykal, Attorney-in-fact
Issuer symbol: TELA
Transactions as of: 14 Nov 2023
Net transactions value: +$44,938
Form type: 4
Filing time: 14 Nov 2023, 20:02:17 UTC
Previous filing: 27 Feb 2023
Next filing: 27 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TELA	Common Stock	Purchase	$44,938	+10,000	+19%	$4.49	62,371	14 Nov 2023	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions ranging from $4.45 to $4.55. The Reporting Person undertakes to provide TELA Bio, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2	Includes 1,079 shares acquired under the Company's employee stock purchase plan on July 31, 2023.

Content

The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions ranging from $4.45 to $4.55. The Reporting Person undertakes to provide TELA Bio, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Includes 1,079 shares acquired under the Company's employee stock purchase plan on July 31, 2023.